PA-X protein of H1N1 subtype influenza virus disables the nasal mucosal dendritic cells for strengthening virulence

References

• Taubenberger JK, Morens DM. Influenza: the once and future pandemic. Public Health Rep. 2010;125(3):16–26.
   PubMedGoogle Scholar
• Klemm C, Boergeling Y, Ludwig S, et al. Immunomodulatory nonstructural proteins of influenza a viruses. Trends Microbiol. 2018;26(7):624–636.
   PubMed Web of Science ®Google Scholar
• Yamayoshi S, Watanabe M, Goto H, et al. Identification of a novel viral protein expressed from the PB2 segment of influenza a virus. J Virol. 2016;90(1):444–456.
   PubMed Web of Science ®Google Scholar
• Dave K, Lee PC. Global geographical and temporal patterns of seasonal influenza and associated climatic factors. Epidemiol Rev. 2019;41(1):51–68.
   PubMed Web of Science ®Google Scholar
• Pavia A. One hundred years after the 1918 pandemic: new concepts for preparing for influenza pandemics. Curr Opin Infect Dis. 2019;32(4):365–371.
   PubMed Web of Science ®Google Scholar
• Reid AH, Taubenberger JK, Fanning TG. Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus. Nat Rev Microbiol. 2004;2(11):909–914.
   PubMed Web of Science ®Google Scholar
• Cao B, Li XW, Mao Y, et al. Clinical features of the initial cases of 2009 pandemic influenza a (H1N1) virus infection in China. N Engl J Med. 2009;361(26):2507–2517. DOI:10.1056/NEJMoa0906612
   PubMed Web of Science ®Google Scholar
• Swine-Origin Influenza AVIT N, Dawood FS, Jain S, et al. Emergence of a novel swine-origin influenza a (H1N1) virus in humans. N Engl J Med. 2009;360:2605–2615.
   PubMed Web of Science ®Google Scholar
• Smole U, Schabussova I, Pickl WF, et al. Murine models for mucosal tolerance in allergy. Semin Immunol. 2017;30:12–27.
   PubMed Web of Science ®Google Scholar
• Qu W, Li N, Yu R, et al. Cationic DDA/TDB liposome as a mucosal vaccine adjuvant for uptake by dendritic cells in vitro induces potent humoural immunity. Artif Cells Nanomed Biotechnol. 2018;46(sup1):852–860. DOI:10.1080/21691401.2018.1438450
   PubMed Web of Science ®Google Scholar
• GeurtsvanKessel CH, Willart MA, van Rijt LS, et al. Clearance of influenza virus from the lung depends on migratory langerin+cd11b− but not plasmacytoid dendritic cells. J Exp Med. 2008;205(7):1621–1634. DOI:10.1084/jem.20071365
   PubMed Web of Science ®Google Scholar
• Ding X, Yang W, Shi X, et al. TNF receptor 1 mediates dendritic cell maturation and CD8 T cell response through two distinct mechanisms. J Immunol. 2011;187(3):1184–1191. DOI:10.4049/jimmunol.1002902
   PubMed Web of Science ®Google Scholar
• Smed-Sorensen A, Chalouni C, Chatterjee B, et al. Influenza a virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells. PLoS Pathog. 2012;8(3):e1002572. DOI:10.1371/journal.ppat.1002572
   PubMed Web of Science ®Google Scholar
• Le Nouen C, Hillyer P, Winter CC, et al. Low CCR7-mediated migration of human monocyte derived dendritic cells in response to human respiratory syncytial virus and human metapneumovirus. PLoS Pathog. 2011;7(6):e1002105. DOI:10.1371/journal.ppat.1002105
   PubMed Web of Science ®Google Scholar
• Palomino-Segura M, Perez L, Farsakoglu Y, et al. Protection against influenza infection requires early recognition by inflammatory dendritic cells through C-type lectin receptor SIGN-R1. Nat Microbiol. 2019;4(11):1930–1940. DOI:10.1038/s41564-019-0506-6
   PubMed Web of Science ®Google Scholar
• Munir S, Le Nouen C, Luongo C, et al. Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells. J Virol. 2008;82(17):8780–8796.
   PubMed Web of Science ®Google Scholar
• Lichtner M, Mastroianni CM, Rossi R, et al. Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 infection. PLoS One. 2011;6(5):e19872. DOI:10.1371/journal.pone.0019872
   PubMed Web of Science ®Google Scholar
• Jagger BW, Wise HM, Kash JC, et al. An overlapping protein-coding region in influenza a virus segment 3 modulates the host response. Science. 2012;337(6091):199–204. DOI:10.1126/science.1222213
   PubMed Web of Science ®Google Scholar
• Hu J, Mo Y, Wang X, et al. PA-X decreases the pathogenicity of highly pathogenic H5N1 influenza a virus in avian species by inhibiting virus replication and host response. J Virol. 2015;89(8):4126–4142. DOI:10.1128/JVI.02132-14
   PubMed Web of Science ®Google Scholar
• Hayashi T, MacDonald LA, Takimoto T. Influenza a virus protein PA-X contributes to viral growth and suppression of the host antiviral and immune responses. J Virol. 2015;89(12):6442–6452.
   PubMed Web of Science ®Google Scholar
• Lee J, Yu H, Li Y, et al. Impacts of different expressions of PA-X protein on 2009 pandemic H1N1 virus replication, pathogenicity and host immune responses. Virology. 2017;504:25–35.
   PubMed Web of Science ®Google Scholar
• Hussain S, Turnbull ML, Wise HM, et al. Mutation of influenza a virus PA-X decreases pathogenicity in chicken embryos and can increase the yield of reassortant candidate vaccine viruses. J Virol. 2019;93(2):18–e01551. DOI:10.1128/JVI.01551-18
   Web of Science ®Google Scholar
• Xu G, Zhang X, Liu Q, et al. PA-X protein contributes to virulence of triple-reassortant H1N2 influenza virus by suppressing early immune responses in swine. Virology. 2017;508:45–53.
   PubMed Web of Science ®Google Scholar
• Rigby RE, Wise HM, Smith N, et al. PA-X antagonises MAVS-dependent accumulation of early type I interferon messenger RNAs during influenza a virus infection. Sci Rep. 2019;9(1):7216.
   PubMedGoogle Scholar
• Nogales A, Rodriguez L, DeDiego ML, et al. Interplay of PA-X and NS1 proteins in replication and pathogenesis of a temperature-sensitive 2009 pandemic H1N1 influenza a virus. J Virol. 2017;91(17):91.
   Web of Science ®Google Scholar
• Gaucherand L, Porter BK, Levene RE, et al. The influenza a virus endoribonuclease PA-X usurps host mRNA processing machinery to limit host gene expression. Cell Rep. 2019;27(3):776–92 e7. DOI:10.1016/j.celrep.2019.03.063
   PubMed Web of Science ®Google Scholar
• Qin T, Ma S, Miao X, et al. Mucosal vaccination for influenza protection enhanced by catalytic immune-adjuvant. Adv Sci (Weinh). 2020;7(18):2000771. DOI:10.1002/advs.202000771
   PubMedGoogle Scholar
• Witschi C, Mrsny RJ. In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery. Pharm Res. 1999;16(3):382–390.
   PubMed Web of Science ®Google Scholar
• Amidi M, Romeijn SG, Borchard G, et al. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release. 2006;111(1–2):107–116.
   PubMed Web of Science ®Google Scholar
• Gao H, Sun Y, Hu J, et al. The contribution of PA-X to the virulence of pandemic 2009 H1N1 and highly pathogenic H5N1 avian influenza viruses. Sci Rep. 2015;5(1):8262. DOI:10.1038/srep08262
   PubMedGoogle Scholar
• Qin T, Zhu J, Ma R, et al. Compatibility between haemagglutinin and neuraminidase drives the recent emergence of novel clade 2.3.4.4 H5Nx avian influenza viruses in China. Transbound Emerg Dis. 2018;65(6):1757–1769. DOI:10.1111/tbed.12949
   PubMed Web of Science ®Google Scholar
• Qin T, Yin Y, Yu Q, et al. CpG oligodeoxynucleotides facilitate delivery of whole inactivated H9N2 influenza virus via transepithelial dendrites of dendritic cells in nasal mucosa. J Virol. 2015;89(11):5904–5918. DOI:10.1128/JVI.00296-15
   PubMed Web of Science ®Google Scholar
• Jonges M, Liu WM, van der Vries E, et al. Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling. J Clin Microbiol. 2010;48(3):928–940. DOI:10.1128/JCM.02045-09
   PubMed Web of Science ®Google Scholar
• Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Epidemiol. 1938;27(3):493–497.
   Google Scholar
• Gauger PC, Vincent AL, Loving CL, et al. Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus. Vaccine. 2011;29(15):2712–2719. DOI:10.1016/j.vaccine.2011.01.082
   PubMed Web of Science ®Google Scholar
• Qin T, Ma R, Yin Y, et al. Catalytic inactivation of influenza virus by iron oxide nanozyme. Theranostics. 2019;9(23):6920–6935. DOI:10.7150/thno.35826
   PubMed Web of Science ®Google Scholar
• Yin Y, Xu N, Shi Y, et al. Astaxanthin protects dendritic cells from lipopolysaccharide-induced immune dysfunction. Mar Drugs. 2021;19(6):346–361. DOI:10.3390/md19060346
   PubMed Web of Science ®Google Scholar
• Chen S, Miao X, Huangfu D, et al. H5N1 avian influenza virus without 80–84 amino acid deletion at the NS1 protein hijacks the innate immune system of dendritic cells for an enhanced mammalian pathogenicity. Transbound Emerg Dis. 2021;68(4):2401–2413. DOI:10.1111/tbed.13904
   PubMed Web of Science ®Google Scholar
• Choi J, Pant A, Medikonda R, et al. Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma. Oncoimmunology. 2021;10(1):1940673. DOI:10.1080/2162402X.2021.1940673
   PubMed Web of Science ®Google Scholar
• Yin Y, Qin T, Yu Q, et al. Bursopentin (BP5) from chicken bursa of fabricius attenuates the immune function of dendritic cells. Amino Acids. 2014;46(7):1763–1774.
   PubMed Web of Science ®Google Scholar
• Alvarez D, Vollmann EH, von Andrian UH. Mechanisms and consequences of dendritic cell migration. Immunity. 2008;29(3):325–342.
   PubMed Web of Science ®Google Scholar
• Reise, Reis E Sousa C, Sousa C. Dendritic cells in a mature age. Nat Rev Immunol. 2006;6(6):476–483.
   PubMed Web of Science ®Google Scholar
• Hu J, Ma C, Liu X. PA-X: a key regulator of influenza a virus pathogenicity and host immune responses. Med Microbiol Immunol. 2018;207(5–6):255–269.
   PubMed Web of Science ®Google Scholar
• Chen X, Liu S, Goraya MU, et al. Host immune response to influenza a virus infection. Front Immunol. 2018;9:320.
   PubMed Web of Science ®Google Scholar
• Clarkson BD, Heninger E, Harris MG, et al. Innate-adaptive crosstalk: how dendritic cells shape immune responses in the CNS. Adv Exp Med Biol. 2012;946:309–333.
   PubMed Web of Science ®Google Scholar
• Reizis B. Plasmacytoid dendritic cells: development, regulation, and function. Immunity. 2019;50(1):37–50.
   PubMed Web of Science ®Google Scholar
• Ballesteros-Tato A, Leon B, Lund FE, et al. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat Immunol. 2010;11(3):216–224.
   PubMed Web of Science ®Google Scholar
• van Rijt LS, Jung S, Kleinjan A, et al. In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med. 2005;201(6):981–991. DOI:10.1084/jem.20042311
   PubMed Web of Science ®Google Scholar
• Sung SS, Fu SM, Rose CE Jr., et al. A major lung CD103 (α E)-β 7 integrin-positive epithelial dendritic cell population expressing langerin and tight junction proteins. J Immunol. 2006;176(4):2161–2172.
   PubMed Web of Science ®Google Scholar
• Medoff BD, Seung E, Hong S, et al. Cd11b+ myeloid cells are the key mediators of Th2 cell homing into the airway in allergic inflammation. J Immunol. 2009;182(1):623–635. DOI:10.4049/jimmunol.182.1.623
   PubMed Web of Science ®Google Scholar
• Sinclair J. Manipulation of dendritic cell functions by human cytomegalovirus. Expert Rev Mol Med. 2008;10:e35.
   PubMedGoogle Scholar
• Ouaguia L, Dufeu-Duchesne T, Leroy V, et al. Hepatitis B virus exploits C-type lectin receptors to hijack cDc1s, cDc2s and pDcs. Clin Transl Immunology. 2020;9(12):e1208. DOI:10.1002/cti2.1208
   PubMed Web of Science ®Google Scholar
• Lin J, Cao Y, Shah AU, et al. Inhibition of the antigen-presenting ability of dendritic cells by non-structural protein 2 of influenza a virus. Vet Microbiol. 2022;267:109392.
   PubMed Web of Science ®Google Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245–252.
   PubMed Web of Science ®Google Scholar
• Min WP, Zhou D, Ichim TE, et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol. 2003;170(3):1304–1312. DOI:10.4049/jimmunol.170.3.1304
   PubMed Web of Science ®Google Scholar
• Jensen SS, Gad M. Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity. J Inflamm (Lond). 2010;7(1):37.
   PubMedGoogle Scholar
• Alnaeeli M, Penninger JM, Teng YT. Immune interactions with CD4+ T cells promote the development of functional osteoclasts from murine CD11c+ dendritic cells. J Immunol. 2006;177(5):3314–3326.
   PubMed Web of Science ®Google Scholar
• Akbar SK, Horiike N, Onji M. Prognostic importance of antigen-presenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrier. Immunology. 1999;96(1):98–108.
   PubMed Web of Science ®Google Scholar
• Kimura MY, Hayashizaki K, Tokoyoda K, et al. Crucial role for CD69 in allergic inflammatory responses: cD69-Myl9 system in the pathogenesis of airway inflammation. Immunol Rev. 2017;278(1):87–100.
   PubMed Web of Science ®Google Scholar
• Cibrian D, Sanchez-Madrid F. CD69: from activation marker to metabolic gatekeeper. Eur J Immunol. 2017;47(6):946–953.
   PubMed Web of Science ®Google Scholar
• Sarajlic M, Neuper T, Fohrenbach Quiroz KT, et al. IL-1β Induces SOCS2 expression in human dendritic cells. Int J Mol Sci. 2019;20(23):20. DOI:10.3390/ijms20235931
   Web of Science ®Google Scholar
• Longhi MP, Wright K, Lauder SN, et al. Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells. PLoS Pathog. 2008;4(2):e1000006. DOI:10.1371/journal.ppat.1000006
   PubMed Web of Science ®Google Scholar
• Kostinov MP, Akhmatova NK, Khromova EA, et al. Cytokine profile in human peripheral blood mononuclear leukocytes exposed to immunoadjuvant and adjuvant-Free vaccines against influenza. Front Immunol. 2020;11:1351.
   PubMed Web of Science ®Google Scholar
• WKE I, Hoshi N, Shouval DS, et al. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science. 2017;356(6337):513–519.
   PubMed Web of Science ®Google Scholar
• Zhao S, Gao Q, Qin T, et al. Effects of virulent and attenuated transmissible gastroenteritis virus on the ability of porcine dendritic cells to sample and present antigen. Vet Microbiol. 2014;171(1–2):74–86. DOI:10.1016/j.vetmic.2014.03.017
   PubMed Web of Science ®Google Scholar